Reduction Mammoplasty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients aged 18 or older; 2. Patients with unilateral breast cancer who are scheduled to undergo therapeutic reduction mammoplasty on the affected side and contralateral (healthy-side) reduction mammoplasty for symmetry; 3. No smoking history or having quit smoking for more than 4 weeks (inclusive); 4. Willing to participate voluntarily after receiving adequate informed consent and having signed the Informed Consent Form.
Exclusion criteria
Exclusion criteria: 1. Patients who have received prior radiotherapy; 2. Patients with uncontrolled diabetes mellitus, severe cardiovascular disease, cardiac insufficiency, or significant hepatic, renal, or hematologic disorders, or other serious systemic diseases; 3. Patients with psychiatric disorders or active psychiatric symptoms; 4. Patients who are pregnant, breastfeeding, or planning to conceive during the study period; 5. Patients currently participating in another clinical trial that may interfere with this study; 6. Patients with poor compliance who are unable or unlikely to adhere to the required study procedures, assessments, or follow-up visits; 7. Patients whom the investigator deems otherwise unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in breast ptosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Breast-Q (Reduction Mammoplasty Module) scores;Assessment of aesthetic outcomes of the breast; | — |
Countries
China
Contacts
Fudan University Cancer Hospital